Best Practices in the Development and Validation of Physiologically Based Biopharmaceutics Modeling. A Workshop Summary Report

Authors:

Abstract
No abstract available
Funding Information
  • Center of Excellence in Regulatory Science and Innovation
  • US Food & Drug Administration (U01FD005946)

This publication has 32 references indexed in Scilit: